Europe Veterinary Pain Management Market - Industry Trends and Forecast to 2032

TABLE OF CONTENTS

1 INTRODUCTION 29

• 1.1 OBJECTIVES OF THE STUDY 29
• 1.2 MARKET DEFINITION 29
• 1.3 OVERVIEW OF THE EUROPE VETERINARY PAIN MANAGEMENT MARKET 29
• 1.4 CURRENCY AND PRICING 31
• 1.5 LIMITATIONS 31
• 1.6 MARKETS COVERED 32

2 MARKET SEGMENTATION 35

• 2.1 MARKETS COVERED 35
• 2.2 GEOGRAPHICAL SCOPE 36
• 2.3 YEARS CONSIDERED FOR THE STUDY 37
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 38
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
• 2.6 MULTIVARIATE MODELLING 42
• 2.7 MARKET END USER COVERAGE GRID 42
• 2.8 PRODUCT LIFELINE CURVE 43
• 2.9 DBMR MARKET POSITION GRID 44
• 2.10 VENDOR SHARE ANALYSIS 45
• 2.11 SECONDARY SOURCES 46
• 2.12 ASSUMPTIONS 46

3 EXECUTIVE SUMMARY 47

4 PREMIUM INSIGHTS 50

• 4.1 PESTEL ANALYSIS 51
• 4.2 PORTER'S FIVE FORCES 52
• 4.3 BRAND REVENUE ANALYSIS 53

5 MARKET OVERVIEW 54

• 5.1 DRIVERS 56
  • 5.1.1 INCREASING PET OWNERSHIP 56
  • 5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 56
  • 5.1.3 GROWING INCIDENCES OF PET DISEASES 57
  • 5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 57
• 5.2 RESTRAINTS 58
  • 5.2.1 INCREASING PET CARE COSTS 58
  • 5.2.2 STRICT REGULATORY GUIDELINES 58 
• 5.3 OPPORTUNITIES 59
  • 5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 59
  • 5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 60
  • 5.3.3 TECHNOLOGICAL ADVANCEMENTS 60
• 5.4 CHALLENGES 61
  • 5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 61
  • 5.4.2 RESISTANCE TO MEDICATIONS 61

6 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 62

• 6.1 OVERVIEW 63
• 6.2 ANALGESICS 64
  • 6.2.1 ANTI- INFLAMMATORY (NSAIDS) 64
    • 6.2.1.1 CARPROFEN 65
    • 6.2.1.2 MELOXICAM 65
    • 6.2.1.3 PHENYLBUTAZONE 65
    • 6.2.1.4 ACETAMINOPHEN 65
    • 6.2.1.5 FIROCOXIB 65
    • 6.2.1.6 DERACOXIB 65
    • 6.2.1.7 OTHERS 66
  • 6.2.2 OPIOIDS 66
    • 6.2.2.1 MU AGONISTS 66
      • 6.2.2.1.1 METHADONE 67
      • 6.2.2.1.2 MEPERIDINE 67
      • 6.2.2.1.3 MORPHINE 67
      • 6.2.2.1.4 OXYMORPHONE 67
      • 6.2.2.1.5 OTHERS 67
    • 6.2.2.2 PARTIAL MU AGONIST 67
      • 6.2.2.2.1 BUPRENORPHINE 67
      • 6.2.2.2.2 OTHERS 68
    • 6.2.2.3 KAPPA AGONIST MU ANTAGONIST 68
      • 6.2.2.3.1 BUTORPHANOL 68
      • 6.2.2.3.2 OTHERS 68
• 6.3 CORTICOSTEROIDS 69
  • 6.3.1 DEXAMETHASONE 69
  • 6.3.2 PREDNISOLONE 69
  • 6.3.3 PREDNISONE 69
  • 6.3.4 OTHERS 70
• 6.4 ALPHA 2 AGONISTS 70 

7 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 71

• 7.1 OVERVIEW 72
• 7.2 BRANDED 73
• 7.3 GENERIC 73

8 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 74

• 8.1 OVERVIEW 75
• 8.2 PRESCRIPTION BASED 76
• 8.3 OTC 76

9 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 77

• 9.1 OVERVIEW 78
• 9.2 COMPANION ANIMAL 79
  • 9.2.1 CANINE 80
  • 9.2.2 EQUINE 80
  • 9.2.3 FELINE 80
  • 9.2.4 OTHERS 80
• 9.3 PRODUCTION ANIMAL 80
  • 9.3.1 CATTLE 81
  • 9.3.2 SWINE 81
  • 9.3.3 POULTRY 81
  • 9.3.4 FISH 81
  • 9.3.5 OTHERS 81

10 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 82

• 10.1 OVERVIEW 83
• 10.2 CHRONIC PAIN 84
• 10.3 ACUTE PAIN 85
• 10.4 POST OPERATIVE PAIN 85
• 10.5 DENTAL PAIN 86

11 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 87

• 11.1 OVERVIEW 88
• 11.2 SOLID 89
  • 11.2.1 TABLET 89
  • 11.2.2 POWDER 90
  • 11.2.3 OTHERS 90 
• 11.3 LIQUID 90
  • 11.3.1 SOLUTION 90
  • 11.3.2 SYRUP 91
  • 11.3.3 SUSPENSION 91
  • 11.3.4 OTHERS 91
• 11.4 SEMI SOLID 91
  • 11.4.1 GEL 92
  • 11.4.2 CREAM 92
  • 11.4.3 OTHERS 92

12 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 93

• 12.1 OVERVIEW 94
• 12.2 PARENTERAL 95
• 12.3 ORAL 96
• 12.4 TOPICAL 96

13 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER 97

• 13.1 OVERVIEW 98
• 13.2 VETERINARY HOSPITALS 99
• 13.3 VETERINARY CLINICS 100
• 13.4 PET SHOPS 100
• 13.5 ANIMAL FARMS 101
• 13.6 ACADEMIC & RESEARCH INSTITUTES 101
• 13.7 OTHERS 102

14 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 103

• 14.1 EUROPE 104
  • 14.1.1 GERMANY 112
  • 14.1.2 FRANCE 119
  • 14.1.3 U K 126
  • 14.1.4 ITALY 133
  • 14.1.5 SPAIN 140
  • 14.1.6 NETHERLANDS 147
  • 14.1.7 RUSSIA 154
  • 14.1.8 SWITZERLAND 161
  • 14.1.9 POLAND 168
  • 14.1.10 BELGIUM 175
  • 14.1.11 TURKEY 182
  • 14.1.12 SWEDEN 189
  • 14.1.13 DENMARK 196
  • 14.1.14 NORWAY 203
  • 14.1.15 FINLAND 210
  • 14.1.16 REST OF EUROPE 217

15 EUROPE VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 224

• 15.1 COMPANY SHARE ANALYSIS: EUROPE 224

16 SWOT ANALYSIS 225

17 COMPANY PROFILE 226

• 17.1 ZOETIS SERVICES LLC 226
  • 17.1.1 COMPANY SNAPSHOT 226
  • 17.1.2 COMPANY SHARE ANALYSIS 226
  • 17.1.3 PRODUCT PORTFOLIO 227
  • 17.1.4 RECENT DEVELOPMENTS 227
• 17.2 ELANCO 228
  • 17.2.1 COMPANY SNAPSHOT 228
  • 17.2.2 REVENUE ANALYSIS 228
  • 17.2.3 COMPANY SHARE ANALYSIS 229
  • 17.2.4 PRODUCT PORTFOLIO 229
  • 17.2.5 RECENT DEVELOPMENT 229
• 17.3 MERCK & CO., INC. 230
  • 17.3.1 COMPANY SNAPSHOT 230
  • 17.3.2 REVENUE ANALYSIS 230
  • 17.3.3 COMPANY SHARE ANALYSIS 231
  • 17.3.4 PRODUCT PORTFOLIO 231
  • 17.3.5 RECENT DEVELOPMENT 231
• 17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 232
  • 17.4.1 COMPANY SNAPSHOT 232
  • 17.4.2 COMPANY SHARE ANALYSIS 232
  • 17.4.3 PRODUCT PORTFOLIO 233
  • 17.4.4 RECENT DEVELOPMENT 233
• 17.5 VETOQUINOL 234
  • 17.5.1 COMPANY SNAPSHOT 234
  • 17.5.2 REVENUE ANALYSIS 234
  • 17.5.3 COMPANY SHARE ANALYSIS 235
  • 17.5.4 PRODUCT PORTFOLIO 235
  • 17.5.5 RECENT DEVELOPMENTS 235 
• 17.6 BIMEDA, INC. 237
  • 17.6.1 COMPANY SNAPSHOT 237
  • 17.6.2 PRODUCT PORTFOLIO 237
  • 17.6.3 RECENT DEVELOPMENT 237
• 17.7 CEVA ANIMAL HEALTH, LLC 238
  • 17.7.1 COMPANY SNAPSHOT 238
  • 17.7.2 PRODUCT PORTFOLIO 238
  • 17.7.3 RECENT DEVELOPMENT 238
• 17.8 CHANELLE PHARMA 239
  • 17.8.1 COMPANY SNAPSHOT 239
  • 17.8.2 PRODUCT PORTFOLIO 239
  • 17.8.3 RECENT DEVELOPMENT 239
• 17.9 DECHRA PHARMACEUTICALS PLC 240
  • 17.9.1 COMPANY SNAPSHOT 240
  • 17.9.2 REVENUE ANALYSIS 240
  • 17.9.3 PRODUCT PORTFOLIO 241
  • 17.9.4 RECENT DEVELOPMENTS 241
• 17.10 DURVET ANIMAL HEALTH PRODUCTS 242
  • 17.10.1 COMPANY SNAPSHOT 242
  • 17.10.2 PRODUCT PORTFOLIO 242
  • 17.10.3 RECENT DEVELOPMENT 242
• 17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 243
  • 17.11.1 COMPANY SNAPSHOT 243
  • 17.11.2 PRODUCT PORTFOLIO 243
  • 17.11.3 RECENT DEVELOPMENTS 243
• 17.12 NORBROOK 245
  • 17.12.1 COMPANY SNAPSHOT 245
  • 17.12.2 PRODUCT PORTFOLIO 245
  • 17.12.3 RECENT DEVELOPMENT 245
• 17.13 VIRBAC 246
  • 17.13.1 COMPANY SNAPSHOT 246
  • 17.13.2 REVENUE ANALYSIS 246
  • 17.13.3 PRODUCT PORTFOLIO 247
  • 17.13.4 RECENT DEVELOPMENT 247

18 QUESTIONNAIRE 248

19 RELATED REPORTS 252

LIST OF TABLES

• TABLE 1 BRAND REVENUE ANALYSIS FOR VETERINARY PAIN MANAGEMENT MARKET 53
• TABLE 2 NUMBER OF U.S. HOUSEHOLD-OWNED PET ANIMALS 56
• TABLE 3 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
• TABLE 4 EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
• TABLE 5 EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
• TABLE 6 EUROPE ANTI- INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 65
• TABLE 7 EUROPE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
• TABLE 8 EUROPE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
• TABLE 9 EUROPE PARTIAL MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 67
• TABLE 10 EUROPE KAPPA AGONIST MU ANTAGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 68
• TABLE 11 EUROPE CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
• TABLE 12 EUROPE CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 69
• TABLE 13 EUROPE ALPHA-2 AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
• TABLE 14 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 73
• TABLE 15 EUROPE BRANDED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
• TABLE 16 EUROPE GENERIC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
• TABLE 17 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 76
• TABLE 18 EUROPE PRESCRIPTION BASED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
• TABLE 19 EUROPE OTC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
• TABLE 20 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 79
• TABLE 21 EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
• TABLE 22 EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 79
• TABLE 23 EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
• TABLE 24 EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 81
• TABLE 25 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 84
• TABLE 26 EUROPE CHRONIC PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 84
• TABLE 27 EUROPE ACUTE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
• TABLE 28 EUROPE POST OPERATIVE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
• TABLE 29 EUROPE DENTAL PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
• TABLE 30 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 89
• TABLE 31 EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 89
• TABLE 32 EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 89
• TABLE 33 EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 90
• TABLE 34 EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 90
• TABLE 35 EUROPE SEMI SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 91
• TABLE 36 EUROPE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 91
• TABLE 37 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 95
• TABLE 38 EUROPE PARENTERAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
• TABLE 39 EUROPE ORAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
• TABLE 40 EUROPE TOPICAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
• TABLE 41 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 99
• TABLE 42 EUROPE VETERINARY HOSPITALS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
• TABLE 43 EUROPE VETERINARY CLINICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
• TABLE 44 EUROPE PET SHOPS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
• TABLE 45 EUROPE ANIMAL FARMS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
• TABLE 46 EUROPE ACADEMIC & RESEARCH INSTITUTES IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
• TABLE 47 EUROPE OTHERS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
• TABLE 48 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 104
• TABLE 49 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 50 EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 51 EUROPE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 52 EUROPE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
• TABLE 53 EUROPE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
• TABLE 54 EUROPE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
• TABLE 55 EUROPE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
• TABLE 56 EUROPE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
• TABLE 57 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 107
• TABLE 58 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 108
• TABLE 59 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 108
• TABLE 60 EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 108
• TABLE 61 EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 109
• TABLE 62 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 109
• TABLE 63 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 110
• TABLE 64 EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 110
• TABLE 65 EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 110
• TABLE 66 EUROPE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 111
• TABLE 67 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 111
• TABLE 68 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 111
• TABLE 69 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
• TABLE 70 GERMANY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
• TABLE 71 GERMANY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
• TABLE 72 GERMANY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
• TABLE 73 GERMANY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
• TABLE 74 GERMANY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
• TABLE 75 GERMANY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
• TABLE 76 GERMANY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
• TABLE 77 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 114
• TABLE 78 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 115
• TABLE 79 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 115
• TABLE 80 GERMANY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 115
• TABLE 81 GERMANY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 82 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 116
• TABLE 83 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 116
• TABLE 84 GERMANY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 117
• TABLE 85 GERMANY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 117
• TABLE 86 GERMANY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 117
• TABLE 87 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 118
• TABLE 88 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
• TABLE 89 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 90 FRANCE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 91 FRANCE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 92 FRANCE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 93 FRANCE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 94 FRANCE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 95 FRANCE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
• TABLE 96 FRANCE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
• TABLE 97 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 121
• TABLE 98 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 122
• TABLE 99 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 122
• TABLE 100 FRANCE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 122
• TABLE 101 FRANCE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 102 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 123
• TABLE 103 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 124
• TABLE 104 FRANCE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 124
• TABLE 105 FRANCE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 124
• TABLE 106 FRANCE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 125
• TABLE 107 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 125
• TABLE 108 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
• TABLE 109 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
• TABLE 110 U.K. ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
• TABLE 111 U.K. ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
• TABLE 112 U.K. OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
• TABLE 113 U.K. MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
• TABLE 114 U.K. PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
• TABLE 115 U.K. KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
• TABLE 116 U.K. CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
• TABLE 117 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 128
• TABLE 118 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 129
• TABLE 119 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 129
• TABLE 120 U.K. COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 129
• TABLE 121 U.K. PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 122 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 130
• TABLE 123 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 130
• TABLE 124 U.K. SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 131
• TABLE 125 U.K. LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 131
• TABLE 126 U.K. SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 131
• TABLE 127 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 132
• TABLE 128 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
• TABLE 129 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 130 ITALY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 131 ITALY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 132 ITALY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
• TABLE 133 ITALY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
• TABLE 134 ITALY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
• TABLE 135 ITALY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
• TABLE 136 ITALY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
• TABLE 137 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 135
• TABLE 138 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 136
• TABLE 139 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 136
• TABLE 140 ITALY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 136
• TABLE 141 ITALY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 142 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 137
• TABLE 143 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 137
• TABLE 144 ITALY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 138
• TABLE 145 ITALY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 138
• TABLE 146 ITALY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 138
• TABLE 147 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 139
• TABLE 148 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
• TABLE 149 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
• TABLE 150 SPAIN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
• TABLE 151 SPAIN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
• TABLE 152 SPAIN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 153 SPAIN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 154 SPAIN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 155 SPAIN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
• TABLE 156 SPAIN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
• TABLE 157 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 142
• TABLE 158 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 143
• TABLE 159 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 143
• TABLE 160 SPAIN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 143
• TABLE 161 SPAIN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 162 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 144
• TABLE 163 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 144
• TABLE 164 SPAIN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 145
• TABLE 165 SPAIN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 145
• TABLE 166 SPAIN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 145
• TABLE 167 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 146
• TABLE 168 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
• TABLE 169 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
• TABLE 170 NETHERLANDS ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
• TABLE 171 NETHERLANDS ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
• TABLE 172 NETHERLANDS OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
• TABLE 173 NETHERLANDS MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
• TABLE 174 NETHERLANDS PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
• TABLE 175 NETHERLANDS KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149
• TABLE 176 NETHERLANDS CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149
• TABLE 177 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 149
• TABLE 178 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 150
• TABLE 179 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 150
• TABLE 180 NETHERLANDS COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 150
• TABLE 181 NETHERLANDS PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 182 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 151
• TABLE 183 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 152
• TABLE 184 NETHERLANDS SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 152
• TABLE 185 NETHERLANDS LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 152
• TABLE 186 NETHERLANDS SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 153
• TABLE 187 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 153
• TABLE 188 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 153
• TABLE 189 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 190 RUSSIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 191 RUSSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 192 RUSSIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
• TABLE 193 RUSSIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
• TABLE 194 RUSSIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
• TABLE 195 RUSSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
• TABLE 196 RUSSIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
• TABLE 197 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 156
• TABLE 198 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 157
• TABLE 199 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 157
• TABLE 200 RUSSIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 157

• TABLE 201 RUSSIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 202 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 158
• TABLE 203 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 158
• TABLE 204 RUSSIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 159
• TABLE 205 RUSSIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 159
• TABLE 206 RUSSIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 159
• TABLE 207 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 160
• TABLE 208 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
• TABLE 209 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 210 SWITZERLAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 211 SWITZERLAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 212 SWITZERLAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
• TABLE 213 SWITZERLAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
• TABLE 214 SWITZERLAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
• TABLE 215 SWITZERLAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
• TABLE 216 SWITZERLAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
• TABLE 217 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 163
• TABLE 218 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 164
• TABLE 219 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 164
• TABLE 220 SWITZERLAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 164
• TABLE 221 SWITZERLAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 222 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 165
• TABLE 223 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 166
• TABLE 224 SWITZERLAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 166
• TABLE 225 SWITZERLAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 166
• TABLE 226 SWITZERLAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 167
• TABLE 227 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 167
• TABLE 228 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
• TABLE 229 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 230 POLAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 231 POLAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 232 POLAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
• TABLE 233 POLAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
• TABLE 234 POLAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
• TABLE 235 POLAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
• TABLE 236 POLAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
• TABLE 237 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 170
• TABLE 238 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 171
• TABLE 239 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 171
• TABLE 240 POLAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 171
• TABLE 241 POLAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 172
• TABLE 242 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 172
• TABLE 243 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 173
• TABLE 244 POLAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 173
• TABLE 245 POLAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 173
• TABLE 246 POLAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 174
• TABLE 247 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 174
• TABLE 248 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 174
• TABLE 249 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
• TABLE 250 BELGIUM ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
• TABLE 251 BELGIUM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
• TABLE 252 BELGIUM OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
• TABLE 253 BELGIUM MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
• TABLE 254 BELGIUM PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
• TABLE 255 BELGIUM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
• TABLE 256 BELGIUM CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
• TABLE 257 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 177
• TABLE 258 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 178
• TABLE 259 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 178
• TABLE 260 BELGIUM COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 178
• TABLE 261 BELGIUM PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 179
• TABLE 262 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 179
• TABLE 263 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 180
• TABLE 264 BELGIUM SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 180
• TABLE 265 BELGIUM LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 180
• TABLE 266 BELGIUM SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 181
• TABLE 267 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 181
• TABLE 268 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 181
• TABLE 269 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
• TABLE 270 TURKEY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
• TABLE 271 TURKEY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
• TABLE 272 TURKEY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
• TABLE 273 TURKEY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
• TABLE 274 TURKEY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
• TABLE 275 TURKEY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 184
• TABLE 276 TURKEY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 184
• TABLE 277 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 184
• TABLE 278 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 185
• TABLE 279 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 185
• TABLE 280 TURKEY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 185
• TABLE 281 TURKEY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 186
• TABLE 282 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 186
• TABLE 283 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 186
• TABLE 284 TURKEY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 187
• TABLE 285 TURKEY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 187
• TABLE 286 TURKEY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 187
• TABLE 287 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 188
• TABLE 288 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 188
• TABLE 289 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
• TABLE 290 SWEDEN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
• TABLE 291 SWEDEN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
• TABLE 292 SWEDEN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
• TABLE 293 SWEDEN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
• TABLE 294 SWEDEN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
• TABLE 295 SWEDEN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
• TABLE 296 SWEDEN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
• TABLE 297 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 191
• TABLE 298 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 192
• TABLE 299 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 192
• TABLE 300 SWEDEN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 192
• TABLE 301 SWEDEN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 193
• TABLE 302 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 193
• TABLE 303 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 193
• TABLE 304 SWEDEN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 194
• TABLE 305 SWEDEN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 194
• TABLE 306 SWEDEN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 194
• TABLE 307 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 195
• TABLE 308 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 195
• TABLE 309 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
• TABLE 310 DENMARK ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
• TABLE 311 DENMARK ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
• TABLE 312 DENMARK OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
• TABLE 313 DENMARK MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
• TABLE 314 DENMARK PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
• TABLE 315 DENMARK KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 198
• TABLE 316 DENMARK CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 198
• TABLE 317 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 198
• TABLE 318 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 199
• TABLE 319 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 199
• TABLE 320 DENMARK COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 199
• TABLE 321 DENMARK PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 200
• TABLE 322 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 200
• TABLE 323 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 200
• TABLE 324 DENMARK SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 201
• TABLE 325 DENMARK LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 201
• TABLE 326 DENMARK SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 201
• TABLE 327 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 202
• TABLE 328 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 202
• TABLE 329 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
• TABLE 330 NORWAY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
• TABLE 331 NORWAY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
• TABLE 332 NORWAY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
• TABLE 333 NORWAY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
• TABLE 334 NORWAY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
• TABLE 335 NORWAY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 205
• TABLE 336 NORWAY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 205
• TABLE 337 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 205
• TABLE 338 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 206
• TABLE 339 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 206
• TABLE 340 NORWAY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 206
• TABLE 341 NORWAY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 207
• TABLE 342 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 207
• TABLE 343 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 208
• TABLE 344 NORWAY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 208
• TABLE 345 NORWAY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 208
• TABLE 346 NORWAY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 209
• TABLE 347 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 209
• TABLE 348 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 209
• TABLE 349 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 210
• TABLE 350 FINLAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 210
• TABLE 351 FINLAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 210
• TABLE 352 FINLAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
• TABLE 353 FINLAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
• TABLE 354 FINLAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
• TABLE 355 FINLAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 212
• TABLE 356 FINLAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 212
• TABLE 357 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 212
• TABLE 358 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 213
• TABLE 359 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 213
• TABLE 360 FINLAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 213
• TABLE 361 FINLAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 214
• TABLE 362 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 214
• TABLE 363 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 215
• TABLE 364 FINLAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 215
• TABLE 365 FINLAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 215
• TABLE 366 FINLAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 216
• TABLE 367 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 216
• TABLE 368 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 216
• TABLE 369 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 217
• TABLE 370 REST OF EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 217
• TABLE 371 REST OF EUROPE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 217
• TABLE 372 REST OF EUROPE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 218
• TABLE 373 REST OF EUROPE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 218
• TABLE 374 REST OF EUROPE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 218
• TABLE 375 REST OF EUROPE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 219
• TABLE 376 REST OF EUROPE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 219
• TABLE 377 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 219
• TABLE 378 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 220
• TABLE 379 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 220
• TABLE 380 REST OF EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 220
• TABLE 381 REST OF EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 221
• TABLE 382 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 221
• TABLE 383 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 221
• TABLE 384 REST OF EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 222
• TABLE 385 REST OF EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 222
• TABLE 386 REST OF EUROPE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 222
• TABLE 387 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 223
• TABLE 388 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 223

LIST OF FIGURES

• FIGURE 1 EUROPE VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 35
• FIGURE 2 EUROPE VETERINARY PAIN MANAGEMENT MARKET: DATA TRIANGULATION 38
• FIGURE 3 EUROPE VETERINARY PAIN MANAGEMENT MARKET: DROC ANALYSIS 39
• FIGURE 4 EUROPE VETERINARY PAIN MANAGEMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 40
• FIGURE 5 EUROPE VETERINARY PAIN MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS 40
• FIGURE 6 EUROPE VETERINARY PAIN MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS 41
• FIGURE 7 EUROPE VETERINARY PAIN MANAGEMENT MARKET: MARKET END USER COVERAGE GRID 42
• FIGURE 8 EUROPE VETERINARY PAIN MANAGEMENT MARKET: DBMR MARKET POSITION GRID 44
• FIGURE 9 EUROPE VETERINARY PAIN MANAGEMENT MARKET: VENDOR SHARE ANALYSIS 45
• FIGURE 10 EUROPE VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 49
• FIGURE 11 INCREASING PET OWNERSHIP AND ADVANCEMENTS IN VETERINARY MEDICINE ARE EXPECTED TO DRIVE THE GROWTH OF THE EUROPE VETERINARY PAIN MANAGEMENT MARKET FROM 2023 TO 2030 50
• FIGURE 12 THE ANALGESICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE VETERINARY PAIN MANAGEMENT MARKET IN 2023 & 2030 50
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR EUROPE VETERINARY PAIN MANAGEMENT MARKET 55
• FIGURE 14 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY PRODUCT TYPE, 2022 63
• FIGURE 15 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY DRUG TYPE, 2022 72
• FIGURE 16 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY MODE OF PURCHASE, 2022 75
• FIGURE 17 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY ANIMAL TYPE, 2022 78
• FIGURE 18 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY PAIN SOURCE, 2022 83
• FIGURE 19 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY DOSAGE, 2022 88
• FIGURE 20 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY ROUTE OF ADMINISTRATION, 2022 94
• FIGURE 21 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY END USER, 2022 98
• FIGURE 22 EUROPE VETERINARY PAIN MANAGEMENT MARKET: COMPANY SHARE 2022 (%) 224